Oaktree Acquisition Corp III Life Sciences Unit
OACCU
5 hedge funds and large institutions have $8.99M invested in Oaktree Acquisition Corp III Life Sciences Unit in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.28% less ownership
Funds ownership: 4.97% → 4.69% (-0.28%)
6% less capital invested
Capital invested by funds: $9.54M → $8.99M (-$547K)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$550K |
| 2 |
CS
Clear Street
New York
|
-$5.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
ADAR1 Capital Management
Austin,
Texas
| $5.48M | – | – | – |
|
|
AAA
2
Affinity Asset Advisors
New York
| $2.66M | – | – | – |
|
|
AC
3
Athos Capital
Hong Kong
| $533K | – | – | – |
|
|
CS
4
Clear Street
New York
| $217K | -$5.2K | -487 | -2% |
|
5
UBS Group
Zurich,
Switzerland
| $104K | – | – | – |
|
|
6
Citigroup
New York
| – | -$550K | -50,900 | Closed |
|
OACCU Hedge Fund Activity: Q3 2025 in Review
5 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Unit (OACCU) for Q3 2025, worth a combined $8.99M — down 5.7% from $9.54M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of OACCU and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Citigroup, exiting entirely with an estimated $550K sold.
- 5 institutional investors held Oaktree Acquisition Corp III Life Sciences Unit (OACCU) as of Q3 2025, down from 6 in Q2 2025.
- Funds reported $8.99M of Oaktree Acquisition Corp III Life Sciences Unit stock for Q3 2025, down 5.7% quarter-over-quarter.
- 0 funds opened new Oaktree Acquisition Corp III Life Sciences Unit positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest Oaktree Acquisition Corp III Life Sciences Unit seller in Q3 2025 was Citigroup, an estimated $550K sold.
Based on aggregated 13F filings for Q3 2025.